Shorts

0:47
Zongertinib Approval Brings First-Line Targeted Therapy to HER2-Mutant NSCLC: Estelamari Rodriguez, MD, MPH
7 months ago
by
Brooke McCormick(+1 more)

1:08
Proactive AE Management Sustains Skin Cancer Treatment Benefits: Todd Schlesinger, MD
7 months ago
by
Brooke McCormick(+2 more)

1:55
Dermatology Innovation, Access Take Center Stage at AAD 2026: Brooke McCormick
7 months ago
by
Brooke McCormick

0:35
Patient Treatment Under the Oncology Care Model: Shiela Plasencia
7 months ago
by
Maggie L. Shaw(+2 more)

0:44
Community Oncology Is Not "Lesser Care": Nicolas Ferreyros
7 months ago
by
Maggie L. Shaw(+1 more)

0:32
Oncology on a Razor-Thin Margin: Christine Pfaff, RPh, MBA
7 months ago
by
Maggie L. Shaw(+1 more)

0:36
The Secret to Better STI Prevention: Jeanne Marrazzo, MD, MPH
7 months ago
by
Skylar Jeremias(+2 more)

0:54
Why One Medical Test Never Tells the Whole Story: David Zhang, MD
7 months ago
by
Sabrina McCrear(+1 more)

0:47
Can Vitamin D Prevent Long COVID?: JoAnn E. Manson, MD
7 months ago
by
Sabrina McCrear(+1 more)

1:21
Trump's Failure to End AIDS: Peter Staley
8 months ago
by
Skylar Jeremias(+2 more)

1:00
The Crisis of Congenital Syphilis: Jeanne Marrazzo, MD, MPH
8 months ago
by
Skylar Jeremias(+2 more)

1:20
Vitamin D Shows Promise in Reducing Inflammation and Long COVID Risk: JoAnn E. Manson, MD
8 months ago
by
Sabrina McCrear(+1 more)

0:29
How Oral Peptides Are Healing Injuries: Christopher Shade, PhD
8 months ago
by
Pearl Steinzor(+1 more)

0:41
How Opioid Guidelines Accidently Pushed Patients: Kerry Schwarz, PharmD
8 months ago
by
Sabrina McCrear(+1 more)

1:06
A New Paradigm for Youth-Centered HIV Prevention: Elona Toska, MSc, DPhil
8 months ago
by
Skylar Jeremias(+2 more)

0:47
GLP-1 Medication Beyond Weight-Loss Indications: Todd T. Brown, MD, PhD
8 months ago
by
Skylar Jeremias(+2 more)

1:15
Unmet NSCLC Needs Persist Despite Advances in Targeted Therapies: Estelamari Rodriguez, MD, MPH
8 months ago
by
Brooke McCormick(+1 more)

0:56
Legal Accountability of AI and Software Companies vs Doctors: Brian Sheppard, JD, LLM
8 months ago
by
Sabrina McCrear(+1 more)

0:52
How Political Policy Is Impacting the Fight Against HIV: Peter Staley
8 months ago
by
Skylar Jeremias(+2 more)

1:50
Rising CRC in Younger Adults Underscores Urgent Need for Earlier Screening: Brooke McCormick
8 months ago
by
Brooke McCormick

0:45
Oral vs Injectable GLP-1s: Eric Levin Talks Cost
8 months ago
by
Giuliana Grossi(+1 more)

0:33
Navigating Employer Coverage for GLP-1 Medications: Eric Levin
8 months ago
by
Giuliana Grossi(+1 more)

1:29
Local Funding Cannot Replace Federal Funding When Addressing HIV: Lindsey Dawson, MA
8 months ago
by
Julia Bonavitacola(+1 more)

0:45
ADAPs Providing HIV Drugs Face Budget Crisis Across the Country: Lindsey Dawson, MA
8 months ago
by
Julia Bonavitacola(+1 more)

1:34
Revised Childhood Vaccine Recommendations Could Affect Herd Immunity: Amy Crawford-Faucher, MD
8 months ago
by
Brooke McCormick(+1 more)

0:33
Building Trust in Clinical Trials for Oncology: Amir Fathi, MD
9 months ago
by
Sabrina McCrear(+1 more)

0:49
Why Clinical Trials Are the Key to Beating Cancer: Amir Fathi, MD
9 months ago
by
Sabrina McCrear(+1 more)

0:30
How Academic Centers Can Support Community Hospitals: Andrew Yee, MD
9 months ago
by
Sabrina McCrear(+1 more)

1:37
Understanding the 3 Pillars of CRC Prevention: Jordan Karlitz, MD
9 months ago
by
Brooke McCormick(+1 more)

0:46
Psoriasis Is More Than Just Skin Deep: James Song, MD
9 months ago
by
Pearl Steinzor(+1 more)
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
4
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
5
